BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 3880656)

  • 21. Comparison of treatment regimens for pediatric lymphoblastic non-Hodgkin's lymphoma: a Childrens Cancer Group study.
    Tubergen DG; Krailo MD; Meadows AT; Rosenstock J; Kadin M; Morse M; King D; Steinherz PG; Kersey JH
    J Clin Oncol; 1995 Jun; 13(6):1368-76. PubMed ID: 7751881
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors of prognostic importance in childhood non-Hodgkin's lymphoma treated with two modified LSA2-L2 protocols. A multivariate analysis approach.
    de Andrea ML; de Camargo B; Correa Alves A; Machado JC; Franco EL
    Cancer; 1988 Jul; 62(2):240-50. PubMed ID: 3383125
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aggressive chemotherapy in the treatment of Burkitt's and non-Burkitt's undifferentiated lymphoma.
    Mazza JJ; Hines JD; Andersen JW; Neiman RS; Mann R; Oken MM; O'Connell MJ
    Leuk Lymphoma; 1995 Jul; 18(3-4):289-96. PubMed ID: 8535195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the LSA2L2 protocol for treatment of childhood non-Hodgkin's lymphoma. A report from the Polish Children's Leukemia/Lymphoma Study Group.
    Bogusławska-Jaworska J; Kościelniak E; Sroczyńska M; Sońta-Jakimczyk D; Armata J; Balwierz W; Ciepielewska D; Kaczmarek-Kanold M; Ochocka M; Radwańska U
    Am J Pediatr Hematol Oncol; 1984; 6(4):363-70. PubMed ID: 6549496
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Results of treatment of advanced-stage Burkitt's lymphoma and B cell (SIg+) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine.
    Murphy SB; Bowman WP; Abromowitch M; Mirro J; Ochs J; Rivera G; Pui CH; Fairclough D; Berard CW
    J Clin Oncol; 1986 Dec; 4(12):1732-9. PubMed ID: 3491184
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Efficacy of modified B-NHL-BFM-90 protocol on Burkitt's lymphoma in Chinese children and adolescents].
    Sun XF; Zhen ZJ; Liu DG; Xia Y; Xiang XJ; Chen XQ; Ling JY; Zheng L; Luo WB; Lin H; He YJ; Guan ZZ
    Ai Zheng; 2007 Dec; 26(12):1339-43. PubMed ID: 18076797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined chemotherapy in 76 children with non-Hodgkin's lymphoma excluding Burkitt's lymphoma.
    Büyükpamukçu M; Sarialioğlu F; Akyüz C; Cevik N
    Br J Cancer; 1987 Nov; 56(5):625-8. PubMed ID: 3426926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies on the pathology of non-Hodgkin's lymphoma of childhood. I. The role of routine histopathology as a prognostic factor. A report from the Children's Cancer Study Group.
    Wilson JF; Jenkin RD; Anderson JR; Chilcote RR; Coccia P; Exelby PR; Kersey J; Kjeldsberg CR; Kushner J; Meadows A
    Cancer; 1984 Apr; 53(8):1695-704. PubMed ID: 6697306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-Hodgkin's lymphoma in children.
    Brecher ML; Sinks LF; Thomas RR; Freeman AI
    Cancer; 1978 May; 41(5):1997-2001. PubMed ID: 348300
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined modality therapy for adults with small noncleaved cell lymphoma (Burkitt's and non-Burkitt's types).
    Bernstein JI; Coleman CN; Strickler JG; Dorfman RF; Rosenberg SA
    J Clin Oncol; 1986 Jun; 4(6):847-58. PubMed ID: 3711961
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-Hodgkin's lymphoma in children: a progress report on the original patients treated with the LSA2-L2 protocol.
    Wollner N; Exelby PR; Lieberman PH
    Cancer; 1979 Dec; 44(6):1990-9. PubMed ID: 389403
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of non-Hodgkin's lymphoma in Mexican children. The effectiveness of chemotherapy during malnutrition.
    Rivera-Luna R; Martinez-Guerra G; Martinez-Avalos A; Altamirano-Alvarez E; Ayon-Cardenas A; Cardenas-Cardoz R; Borrego-Roman R; Lanche-Guevara T; Lopez-Corella E
    Am J Pediatr Hematol Oncol; 1987; 9(4):356-66. PubMed ID: 3326420
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
    Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
    Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Results of a randomized phase III trial in children and adolescents with advanced stage diffuse large cell non-Hodgkin's lymphoma: a Pediatric Oncology Group study.
    Laver JH; Mahmoud H; Pick TE; Hutchison RE; Weinstein HJ; Schwenn M; Weitzman S; Murphy SB; Ochoa S; Shuster JJ
    Leuk Lymphoma; 2002 Jan; 43(1):105-9. PubMed ID: 11908712
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved prognosis in children with intra-abdominal non-Hodgkin's lymphoma following LSA2L2 protocol chemotherapy.
    Wollner N; Wachtel AE; Exelby PR; Centore D
    Cancer; 1980 Jun; 45(12):3034-9. PubMed ID: 7388747
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of children with B-cell non-Hodgkin's lymphoma in developing countries: the experience of a single center in Brazil.
    Klumb CE; Schramm MT; De Resende LM; Carriço MK; Coelho AM; de Meis E; Ferreira RM; Maia RC; Dobbin Jde A
    J Pediatr Hematol Oncol; 2004 Jul; 26(7):462-8. PubMed ID: 15218425
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of a second-generation combination chemotherapeutic regimen (m-BACOD) with a standard regimen (CHOP) for advanced diffuse non-Hodgkin's lymphoma.
    Gordon LI; Harrington D; Andersen J; Colgan J; Glick J; Neiman R; Mann R; Resnick GD; Barcos M; Gottlieb A
    N Engl J Med; 1992 Nov; 327(19):1342-9. PubMed ID: 1383819
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Analysis of therapy results and prognostic factors in children with acute lymphoblastic leukaemia in Warmia and Mazury region: 17-years experience].
    Badowska W
    Med Wieku Rozwoj; 2008; 12(4 Pt 2):1001-7. PubMed ID: 19531816
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage--a report of the Berlin-Frankfurt-Münster Group.
    Reiter A; Schrappe M; Parwaresch R; Henze G; Müller-Weihrich S; Sauter S; Sykora KW; Ludwig WD; Gadner H; Riehm H
    J Clin Oncol; 1995 Feb; 13(2):359-72. PubMed ID: 7844597
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prognostic changes in juvenile abdominal non-Hodgkin's lympomas (NHL)].
    Sigg C; Plüss HJ; Hitzig WH
    Schweiz Med Wochenschr; 1980 Jul; 110(27-28):1056-9. PubMed ID: 7423149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.